Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Data mining analysis of miR-638 and key genes interaction in cisplatin resistant triple-negative breast cancer

Indonesian Journal of Biotechnology · Vol. 24 No. 2 (2019) · hlm. 65–73

DOI
10.22146/ijbiotech.48732
ISSN
2089-2241, 0853-8654
Terbit
2019-12-04
Penerbit
Universitas Gadjah Mada
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-sa/4.0

Abstrak

Cisplatn is one of the chemotherapy for the treatment of triple‐negatve breast cancer (TNBC), but its effectveness is limited because of the phenomenon of chemoresistance. miR‐638 was shown to regulate chemoresistance; however, it has never been validated in the cisplatn‐resistant tumor from patents. This present study aimed to identfy the key gene regulatory networks of miR‐638 and evaluate the potental role of the miR‐638 and its targets as potental prognosis biomarkers for cisplatn‐resistance triple‐negatve breast cancer patents. The miR‐638 target was obtained from the miRecords database while the mRNA of chemoresistance biomarker candidate was obtained from the GSE18864 of GEO database, which is mRNA of cisplatn‐resistance TNBC patents. CCND1 and FZD7 are potental candidates for cisplatn chemoresistance biomarkers in patents with TNBC. Moreover, a Kaplan‐Meier survival plot showed that breast cancer patents with low mRNA levels of FZD7 had signifcantly worse overall survival than those in higher mRNA expression group. Taken together, miR‐638 plays a role in cisplatn resistance mechanism through a mechanism involving its target gene CCND1 and FZD7. Overall, miR‐638, CCND1, and FZD7 are candidates for cisplatn biomarker resistance in TNBC.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 157 tautan kepenulisan bersama · 27 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Gadjah Mada
  • National Research and Innovation Agency
  • Kementerian Kesehatan Republik Indonesia
  • Sumatera Institute of Technology
  • Tanjungpura University
  • Universitas Airlangga
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Edy MeiyantoUniversitas Gadjah Mada21
Rohmad Yudi UtomoUniversitas Gadjah Mada4
Dyaningtyas Dewi Pamungkas PutriUniversitas Gadjah Mada4
Ratna Asmah SusidartiUniversitas Gadjah Mada4
Riris Istighfari JenieUniversitas Gadjah Mada3
Lailatul QodriaUniversitas Gadjah Mada2
Gergorius Gena MaranUniversitas Gadjah Mada2
Anindyajati AnindyajatiUniversitas Gadjah Mada2
Muthi IkawatiUniversitas Gadjah Mada2
Yurista GilangUniversitas Gadjah Mada2
Sari HaryantiKementerian Kesehatan Republik Indonesia2
Ratna Dwi RamadaniNational Research and Innovation Agency2
Aditya FitriasariUniversitas Gadjah Mada2
Nadzifa NugraheniUniversitas Gadjah Mada2
Dhania NovitasariUniversitas Gadjah Mada2
Laeli MuntafiahUniversitas Gadjah Mada1
Nur Fitra SariUniversitas Gadjah Mada1
Ghina LintangsariUniversitas Gadjah Mada1
Alma Nuril AliyahUniversitas Gadjah Mada1
Sarmoko SarmokoSumatera Institute of Technology1
Inna ArmandariUniversitas Gadjah Mada1
Kartika Dyah PalupiNational Research and Innovation Agency1
Sofa FaridaUniversitas Gadjah Mada1
Larasati LarasatiUniversitas Gadjah Mada1
Indri KusharyantiTanjungpura University1
Luthfia IndriyaniUniversitas Gadjah Mada1
Nanda Resa PratamaUniversitas Gadjah Mada1
Rita RiataUniversitas Gadjah Mada1
Ediati SasmitoUniversitas Gadjah Mada1
Beni LestariUniversitas Gadjah Mada1
Prisnu TirtanirmalaUniversitas Gadjah Mada1
Erlina RivantiUniversitas Gadjah Mada1
Annishfia Lailatur RohmahUniversitas Gadjah Mada1
Suwijiyo PramonoUniversitas Gadjah Mada1
Retno MurwantiUniversitas Gadjah Mada1
Gagas Pradani Nur IlmawatiUniversitas Gadjah Mada1
Indah HairunisaUniversitas Gadjah Mada1
Juni EkowatiUniversitas Airlangga1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://jurnal.ugm.ac.id/ijbiotech/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Data mining analysis of miR-638 and key genes interaction in cisplatin resistant triple-negative breast cancer</dc:title>
	<dc:creator>Hermawan, Adam</dc:creator>
	<dc:creator>Putri, Herwandhani</dc:creator>
	<dc:subject xml:lang="en-US">miR-638; chemoresistance; triple-negative breast cancer; data mining</dc:subject>
	<dc:description xml:lang="en-US">Cisplatn is one of the chemotherapy for the treatment of triple‐negatve breast cancer (TNBC), but its effectveness is limited because of the phenomenon of chemoresistance. miR‐638 was shown to regulate chemoresistance; however, it has never been validated in the cisplatn‐resistant tumor from patents. This present study aimed to identfy the key gene regulatory networks of miR‐638 and evaluate the potental role of the miR‐638 and its targets as potental prognosis biomarkers for cisplatn‐resistance triple‐negatve breast cancer patents. The miR‐638 target was obtained from the miRecords database while the mRNA of chemoresistance biomarker candidate was obtained from the GSE18864 of GEO database, which is mRNA of cisplatn‐resistance TNBC patents. CCND1 and FZD7 are potental candidates for cisplatn chemoresistance biomarkers in patents with TNBC. Moreover, a Kaplan‐Meier survival plot showed that breast cancer patents with low mRNA levels of FZD7 had signifcantly worse overall survival than those in higher mRNA expression group. Taken together, miR‐638 plays a role in cisplatn resistance mechanism through a mechanism involving its target gene CCND1 and FZD7. Overall, miR‐638, CCND1, and FZD7 are candidates for cisplatn biomarker resistance in TNBC. </dc:description>
	<dc:publisher xml:lang="en-US">Universitas Gadjah Mada</dc:publisher>
	<dc:contributor xml:lang="en-US">-</dc:contributor>
	<dc:date>2019-12-04</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Original Research Articles</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.ugm.ac.id/ijbiotech/article/view/48732</dc:identifier>
	<dc:identifier>10.22146/ijbiotech.48732</dc:identifier>
	<dc:source xml:lang="en-US">Indonesian Journal of Biotechnology; Vol 24, No 2 (2019); 65-73</dc:source>
	<dc:source>2089-2241</dc:source>
	<dc:source>0853-8654</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.ugm.ac.id/ijbiotech/article/view/48732/26442</dc:relation>
	<dc:relation>https://journal.ugm.ac.id/ijbiotech/article/downloadSuppFile/48732/9048</dc:relation>
	<dc:relation>https://journal.ugm.ac.id/ijbiotech/article/downloadSuppFile/48732/9049</dc:relation>
	<dc:relation>https://journal.ugm.ac.id/ijbiotech/article/downloadSuppFile/48732/9050</dc:relation>
	<dc:relation>https://journal.ugm.ac.id/ijbiotech/article/downloadSuppFile/48732/10255</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2019 The Author(s)</dc:rights>
	<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>